Status:
COMPLETED
Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Hemolytic-uremic Syndrome
Escherichia Coli Infections
Eligibility:
All Genders
2+ years
Brief Summary
The Hemolytic Uremic Syndrome (HUS) in its typical form occurs after a food born infection with a shiga-toxin secreting bacteria, usually Escherichia coli of the O157H7 serotype. An outbreak of bloody...
Eligibility Criteria
Inclusion
- All patients with HUS concomitant to the outbreak linked to E. coli O104:H4
Exclusion
- Patient not willing to participate or to sign informed consent
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01406288
Start Date
July 1 2011
End Date
March 1 2012
Last Update
November 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Néphrologie, transplantation dialyse - Hôpital Pellegrin
Bordeaux, France, 33076